-+ 0.00%
-+ 0.00%
-+ 0.00%

Moleculin Biotech Announces Its Miracle Trial Reports 37% Blinded Complete Remission In Venetoclax-failed R/R AML Patients

Benzinga·07/31/2026 12:10:47
Listen to the news

https://www.sec.gov/ix?doc=/Archives/edgar/data/1659617/000143774926025167/mbrx20260729_8k.htm